BlackRock’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.35M | Sell |
1,827,964
-14,268
| -0.8% | -$57.4K | ﹤0.01% | 3510 |
|
|
2025
Q1 | $6.39M | Buy |
1,842,232
+20,266
| +1% | +$70.3K | ﹤0.01% | 3493 |
|
|
2024
Q4 | $12M | Buy |
1,821,966
+191,679
| +12% | +$1.26M | ﹤0.01% | 3291 |
|
|
2024
Q3 | $14.7M | Buy |
1,630,287
+838,703
| +106% | +$7.58M | ﹤0.01% | 3173 |
|
|
2024
Q2 | $12.7M | Buy |
791,584
+128,622
| +19% | +$2.06M | ﹤0.01% | 3195 |
|
|
2024
Q1 | $10.4M | Buy |
662,962
+493,066
| +290% | +$7.73M | ﹤0.01% | 3280 |
|
|
2023
Q4 | $2.28M | Buy |
+169,896
| New | +$2.28M | ﹤0.01% | 3921 |
|